R&D Partner Content The World's Definitive Degrader & Proximity-Based Drugs Even... The 8th Annual TPD & Induced Proximity Summit is the world’s largest and longest-standing forum for proximity-based modalities
R&D Partner Content Welcome to the 7th Exosome-Based Therapeutic Development Sum... Accelerate Therapeutic Efficacy & Delivery Potential of Exosomes & EVs
R&D Partner Content Welcome to the 10th CDD for Biologics Summit Celebrating 10 Years of Computational Drug Development for Biologics Summit
R&D Partner Content 8th Neuropsychiatric Drug Development Summit The Neuropsychiatric Drug Development Summit returns for its eighth year as the industry’s flagship forum, capturing advancements across discovery...
R&D Partner Content 7th TRP Europe | November 2025, Amsterdam | Agenda Released With new targets like HER2 and FAP coming into focus, and promising data emerging beyond PSMA and SSTR2, real momentum is building in the field.
R&D Partner Content 15th World Clinical Biomarkers & Companion Diagnostics Summi... The biomarkers and diagnostics field continues to boom, driven by advancements in genomic profiling, omics, and AI technologies.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.